支持小组组长的经验与硬皮病患者中心干预网络支持小组组长教育计划结果的关系:双臂平行部分嵌套随机对照试验的二次分析。

Brett D Thombs, Brooke Levis, Marie-Eve Carrier, Laura Dyas, Violet Konrad, Maureen Sauvé, Andrea Benedetti
{"title":"支持小组组长的经验与硬皮病患者中心干预网络支持小组组长教育计划结果的关系:双臂平行部分嵌套随机对照试验的二次分析。","authors":"Brett D Thombs, Brooke Levis, Marie-Eve Carrier, Laura Dyas, Violet Konrad, Maureen Sauvé, Andrea Benedetti","doi":"10.1177/23971983241272742","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction/objective: </strong>The Scleroderma Patient-centered Intervention Network Support group Leader EDucation Program was found in a randomized controlled trial to substantially improve leader self-efficacy. Whether the program is effective for leaders with different levels of experience, including candidate leaders with no prior experience and leaders with ⩽3 years experience or ⩾4 years experience, is not known. The objective of the present post hoc secondary analysis was to evaluate outcomes by leader experience, age, and education.</p><p><strong>Methods: </strong>The trial was a pragmatic, two-arm partially nested randomized controlled trial with 1:1 allocation to intervention or waitlist control. Eligible participants were existing or candidate support group leaders. The 13-session leader training was delivered in groups of five to six participants weekly via videoconference in 60- to 90-min sessions. The primary outcome was leader self-efficacy, measured by the Support Group Leader Self-efficacy Scale (SGLSS) immediately post-intervention. Secondary outcomes were Support Group Leader Self-efficacy Scale scores 3 months post-intervention and emotional distress, leader burnout, and volunteer satisfaction post-intervention and 3 months post-intervention. Leaders were classified as having no experience, ⩽3 years experience, or ⩾4 years experience.</p><p><strong>Results: </strong>A total of 148 participants were randomized to intervention (N = 74) or waitlist (N = 74). Compared to leaders with ⩾4 years of experience, Support Group Leader Self-efficacy Scale scores were non-statistically significantly higher post-intervention for leaders with 0-3 years experience and lower for leaders with no experience. The 3 months post-intervention Support Group Leader Self-efficacy Scale scores were significantly lower for leaders without experience and similar for leaders with 0-3 years to those with ⩾4 years experience. There were no differences by experience on other outcomes or by age and education on any outcomes.</p><p><strong>Conclusion: </strong>Support group leader education improved leader self-efficacy but was most effective for leaders with experience prior to initiating the program.</p><p><strong>Trial registration: </strong>NCT03965780; registered on May 29, 2019.</p>","PeriodicalId":17036,"journal":{"name":"Journal of Scleroderma and Related Disorders","volume":" ","pages":"23971983241272742"},"PeriodicalIF":1.4000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561947/pdf/","citationCount":"0","resultStr":"{\"title\":\"Association of support group leader experience with Scleroderma Patient-centered Intervention Network Support group Leader EDucation Program outcomes: Secondary analysis of a two-arm parallel partially nested randomized controlled trial.\",\"authors\":\"Brett D Thombs, Brooke Levis, Marie-Eve Carrier, Laura Dyas, Violet Konrad, Maureen Sauvé, Andrea Benedetti\",\"doi\":\"10.1177/23971983241272742\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction/objective: </strong>The Scleroderma Patient-centered Intervention Network Support group Leader EDucation Program was found in a randomized controlled trial to substantially improve leader self-efficacy. Whether the program is effective for leaders with different levels of experience, including candidate leaders with no prior experience and leaders with ⩽3 years experience or ⩾4 years experience, is not known. The objective of the present post hoc secondary analysis was to evaluate outcomes by leader experience, age, and education.</p><p><strong>Methods: </strong>The trial was a pragmatic, two-arm partially nested randomized controlled trial with 1:1 allocation to intervention or waitlist control. Eligible participants were existing or candidate support group leaders. The 13-session leader training was delivered in groups of five to six participants weekly via videoconference in 60- to 90-min sessions. The primary outcome was leader self-efficacy, measured by the Support Group Leader Self-efficacy Scale (SGLSS) immediately post-intervention. Secondary outcomes were Support Group Leader Self-efficacy Scale scores 3 months post-intervention and emotional distress, leader burnout, and volunteer satisfaction post-intervention and 3 months post-intervention. Leaders were classified as having no experience, ⩽3 years experience, or ⩾4 years experience.</p><p><strong>Results: </strong>A total of 148 participants were randomized to intervention (N = 74) or waitlist (N = 74). Compared to leaders with ⩾4 years of experience, Support Group Leader Self-efficacy Scale scores were non-statistically significantly higher post-intervention for leaders with 0-3 years experience and lower for leaders with no experience. The 3 months post-intervention Support Group Leader Self-efficacy Scale scores were significantly lower for leaders without experience and similar for leaders with 0-3 years to those with ⩾4 years experience. There were no differences by experience on other outcomes or by age and education on any outcomes.</p><p><strong>Conclusion: </strong>Support group leader education improved leader self-efficacy but was most effective for leaders with experience prior to initiating the program.</p><p><strong>Trial registration: </strong>NCT03965780; registered on May 29, 2019.</p>\",\"PeriodicalId\":17036,\"journal\":{\"name\":\"Journal of Scleroderma and Related Disorders\",\"volume\":\" \",\"pages\":\"23971983241272742\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561947/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Scleroderma and Related Disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/23971983241272742\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scleroderma and Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23971983241272742","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言/目的:在一项随机对照试验中发现,硬皮病患者为中心的干预网络支持小组领导者教育计划能显著提高领导者的自我效能。该计划是否对不同经验水平的领导者有效,包括无经验的候选领导者和有⩽3 年经验或⩾4 年经验的领导者,目前尚不清楚。本次事后二次分析的目的是根据领导者的经验、年龄和教育程度对结果进行评估:该试验是一项务实的双臂部分嵌套随机对照试验,1:1 分配到干预组或候补对照组。符合条件的参与者是现有的或候选的支持小组领导者。领导者培训共 13 个课时,每周通过视频会议对 5 至 6 名参与者进行 60 至 90 分钟的分组培训。主要结果是领导者自我效能感,由支持小组领导者自我效能感量表(SGLSS)在干预后立即进行测量。次要结果是干预后 3 个月的支持小组领导者自我效能量表得分,以及干预后和干预后 3 个月的情绪困扰、领导者职业倦怠和志愿者满意度。领导者被分为没有经验、⩽3 年经验或⩾4 年经验:共有 148 名参与者被随机分配到干预组(74 人)或候补组(74 人)。与具有⩾4年工作经验的领导者相比,具有0-3年工作经验的领导者在干预后的支持小组领导者自我效能量表得分明显较高,而没有工作经验的领导者得分则较低,但没有统计学意义。干预后 3 个月,没有经验的领导者的支持小组领导者自我效能感量表得分明显较低,而有 0-3 年经验的领导者与有⩾4 年经验的领导者得分相近。在其他结果上,经验没有差异,在任何结果上,年龄和教育程度也没有差异:结论:支持小组领导者教育提高了领导者的自我效能感,但对在启动该计划之前就有经验的领导者最有效:NCT03965780;注册日期:2019年5月29日。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Association of support group leader experience with Scleroderma Patient-centered Intervention Network Support group Leader EDucation Program outcomes: Secondary analysis of a two-arm parallel partially nested randomized controlled trial.

Introduction/objective: The Scleroderma Patient-centered Intervention Network Support group Leader EDucation Program was found in a randomized controlled trial to substantially improve leader self-efficacy. Whether the program is effective for leaders with different levels of experience, including candidate leaders with no prior experience and leaders with ⩽3 years experience or ⩾4 years experience, is not known. The objective of the present post hoc secondary analysis was to evaluate outcomes by leader experience, age, and education.

Methods: The trial was a pragmatic, two-arm partially nested randomized controlled trial with 1:1 allocation to intervention or waitlist control. Eligible participants were existing or candidate support group leaders. The 13-session leader training was delivered in groups of five to six participants weekly via videoconference in 60- to 90-min sessions. The primary outcome was leader self-efficacy, measured by the Support Group Leader Self-efficacy Scale (SGLSS) immediately post-intervention. Secondary outcomes were Support Group Leader Self-efficacy Scale scores 3 months post-intervention and emotional distress, leader burnout, and volunteer satisfaction post-intervention and 3 months post-intervention. Leaders were classified as having no experience, ⩽3 years experience, or ⩾4 years experience.

Results: A total of 148 participants were randomized to intervention (N = 74) or waitlist (N = 74). Compared to leaders with ⩾4 years of experience, Support Group Leader Self-efficacy Scale scores were non-statistically significantly higher post-intervention for leaders with 0-3 years experience and lower for leaders with no experience. The 3 months post-intervention Support Group Leader Self-efficacy Scale scores were significantly lower for leaders without experience and similar for leaders with 0-3 years to those with ⩾4 years experience. There were no differences by experience on other outcomes or by age and education on any outcomes.

Conclusion: Support group leader education improved leader self-efficacy but was most effective for leaders with experience prior to initiating the program.

Trial registration: NCT03965780; registered on May 29, 2019.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
31
期刊最新文献
Cardiac involvement in systemic sclerosis: A critical review of knowledge gaps and opportunities. Psychosocial moderators of the association between pain intensity and physical function in people with systemic sclerosis. Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review. Systemic sclerosis-associated severe gastric antral vascular ectasia treated with tocilizumab:A case report and review of the literature. Longitudinal association between nailfold capillaroscopy and incident interstitial lung disease: A EUSTAR database analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1